GenusLSE:GNS -2.51%73 Dividend Payout Ratio is 0.36 as of Dec. 2025, which is 3% below its 10-year median of 0.37. GuruFocus rates LSE:GNS with a GF Score™ of 73/100 and a GF Value™ of £20.63 (Fairly Valued). The stock has 5 warning signs investors should review. Among 133 Biotechnology companies, Genus ranks better than 64.66% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Genus's Dividend Payout Ratio for the
months ended in Dec. 2025 was 0.36.
The historical rank and industry rank for Genus's Dividend Payout Ratio or its related term are showing as below:
LSE:GNS'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.3 Med: 0.37 Max: 0.49
Current: 0.32
During the past 13 years, the highest Dividend Payout Ratio of Genus was 0.49. The lowest was 0.30. And the median was 0.37.
LSE:GNS's Dividend Payout Ratio is ranked better than 64.66% of 133
companies
in the Biotechnology industry
Industry Median: 0.44
vs LSE:GNS: 0.32
During the past 5 years, the average Dividends Per Share Growth Rate was 2.40% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 6.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Genus was 25.60% per year. The lowest was -2.60% per year. And the median was 9.80% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Genus (LSE:GNS) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Genus Dividend Payout Ratio Related Terms
Genus Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Genus's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:GNS vs VRTX, REGN, ALNY: Dividend Payout Ratio Comparison
For the Biotechnology subindustry, Genus's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genus Dividend Payout Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Genus's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Genus's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Genus's Dividend Payout Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genus (LSE:GNS) has a Dividend Payout Ratio of 0.36 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Genus and its competitors. This is near median its historical median of 0.37. Over the past decade, Genus' Dividend Payout Ratio has ranged from 0.30 to 0.49. According to the industry distribution chart, Genus ranks #47 out of 133 companies in the Biotechnology industry, placing it in the top 35.3%.
Is Genus' Dividend Payout Ratio too high?
Genus' current Dividend Payout Ratio of 0.36 is near median its 10-year median of 0.37. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 0.49. The Biotechnology industry median Dividend Payout Ratio is 0.44. Genus' value of 0.36 is 18.2% below this industry median. Based on the distribution chart, Genus ranks #47 out of 133 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Genus has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genus' Dividend Payout Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Genus ranks #47 out of 133 companies for Dividend Payout Ratio. This puts Genus in the upper half of its industry. The industry median Dividend Payout Ratio is 0.44. Genus' value of 0.36 is 18.2% below this benchmark. Historically, Genus' own Dividend Payout Ratio has ranged from 0.30 to 0.49 over the past decade. While the company's 10-year median is 0.37 vs. the industry median of 0.44, Genus has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.44, based on 133 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genus's current Dividend Payout Ratio of 0.36 is 18.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Genus and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genus's current Dividend Payout Ratio is 0.36, which is near median its own 10-year median of 0.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genus stock overvalued right now?
Based on GuruFocus' analysis, Genus (LSE:GNS) is currently considered Fairly Valued. The stock's GF Value™ is £20.63, compared to a current price of £20.20 — trading 2.1% below its estimated fair value. The current Dividend Payout Ratio is 0.36, which is near median its 10-year median of 0.37 and 18.2% below the Biotechnology industry median of 0.44. Genus' overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Genus (LSE:GNS), the current Dividend Payout Ratio is 0.36 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genus (LSE:GNS) Overvalued in 2026?
Based on GuruFocus' analysis, Genus stock appears to be undervalued.
The current stock price of £20.20 is trading 2.1% below its estimated GF Value™ of £20.63.
GuruFocus considers Genus to be Fairly Valued.
Key valuation signals for LSE:GNS:
Dividend Payout Ratio: 0.36 (near median its 10-year median of 0.37)
GF Value™: £20.63 vs. price of £20.20 (2.1% below fair value)
Industry Position: 18.2% below the Biotechnology median (#47 of 133)
No single metric tells the full story. See the LSE:GNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genus PLC is an animal genetics company focused on improving cattle and pig populations to support sustainable food production. The company operates through two main business units: one providing bovine genetics mainly for dairy and beef cattle, and the other offering porcine genetics for pork production. Genus develops genetically superior breeding animals using scientific techniques. It generates revenue by selling genetics, including semen and embryos, as well as through related services under multi-year royalty agreements. The principal activities of each segment are: (a) Genus PIC porcine sales business, (b) Genus ABS: bovine sales business, and (c) Genus Research and Development: spending on research and development.
73GF Score
Get the complete analysis for LSE:GNS
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:GNS has been successfully added to your 
